Amoolya Singh is a seasoned biotech and drug discovery executive with a strong focus on technology innovation and computational biology. They served as Vice President of R&D at Amyris Inc from 2011 to 2019 and have held various roles in research and technology, including Chief Technology Officer at DELFI Diagnostics and Head of Discovery Technologies at Calico Life Sciences. They currently sit on the Scientific Advisory Board of GRAIL and serve as a board member for the Damon Runyon Cancer Research Foundation. Amoolya is pursuing a B.S. in Biology and Computer Science and a Ph.D. in Computational Biology from the University of California, Berkeley. With experience on three continents and proficiency in seven languages, they are passionate about bridging science and people.
This person is not in any teams
This person is not in any offices